A Vital Link to Cancer Theranostics
With this high value test:
Oncologists are able to identify patients who won't respond to a drug or
who will respond poorly, reducing trial-and-error prescription and adverse
events, thereby delivering more cost-effective care.
Patients are guaranteed of better outcomes and safer treatments
Pharmaceutical companies lower the cost and time of drug
development, clinical trials and regulatory approval, by pinpointing those
patients most likely to benefit from the new drug being tested.
Copyright All Rights Reserved